TW430661B - Benzenesulfonamide derivative and process for preparing thereof - Google Patents
Benzenesulfonamide derivative and process for preparing thereofInfo
- Publication number
- TW430661B TW430661B TW083111723A TW83111723A TW430661B TW 430661 B TW430661 B TW 430661B TW 083111723 A TW083111723 A TW 083111723A TW 83111723 A TW83111723 A TW 83111723A TW 430661 B TW430661 B TW 430661B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- substituted
- unsubstituted
- formula
- single bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31877993 | 1993-12-17 | ||
| JP14062894 | 1994-06-23 | ||
| JP18355394 | 1994-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW430661B true TW430661B (en) | 2001-04-21 |
Family
ID=27318092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083111723A TW430661B (en) | 1993-12-17 | 1994-12-15 | Benzenesulfonamide derivative and process for preparing thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5589478A (zh) |
| EP (1) | EP0658548B1 (zh) |
| KR (1) | KR100250176B1 (zh) |
| CN (1) | CN1051544C (zh) |
| AT (1) | ATE160341T1 (zh) |
| AU (1) | AU676620B2 (zh) |
| CA (1) | CA2137953C (zh) |
| DE (1) | DE69406900T2 (zh) |
| DK (1) | DK0658548T3 (zh) |
| ES (1) | ES2111237T3 (zh) |
| FI (1) | FI115137B (zh) |
| GR (1) | GR3025855T3 (zh) |
| HK (1) | HK1004333A1 (zh) |
| IL (1) | IL111959A (zh) |
| MY (1) | MY130908A (zh) |
| SG (1) | SG52234A1 (zh) |
| TW (1) | TW430661B (zh) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5736509A (en) * | 1990-12-14 | 1998-04-07 | Texas Biotechnology Corporation | Cyclic peptide surface feature mimics of endothelin |
| US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US6376523B1 (en) | 1994-05-20 | 2002-04-23 | Texas Biotechnology Corporation | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6541498B2 (en) | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6030991A (en) * | 1993-05-20 | 2000-02-29 | Texas Biotechnology Corp. | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| TW313568B (zh) * | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
| JP2930731B2 (ja) * | 1994-12-20 | 1999-08-03 | エフ・ホフマン−ラ ロシュ アーゲー | アリール−及びヘテロアリール−スルホンアミド誘導体、その製造法及びエンドセリンアンタゴニストとしてのその用途 |
| WO1996020177A1 (fr) * | 1994-12-28 | 1996-07-04 | Kowa Co., Ltd. | Derives pyrimidiniques |
| US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| CA2230516C (en) * | 1995-09-06 | 2008-11-18 | Kowa Co., Ltd. | Pyrimidine derivatives |
| CZ260596A3 (en) * | 1995-10-12 | 1997-12-17 | Hoffmann La Roche | Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof |
| DE69612874T2 (de) * | 1995-12-20 | 2001-10-04 | Yamanouchi Pharmaceutical Co., Ltd. | Arylethensulfonamid-derivate und diese enthaltende medikamente |
| US5977117A (en) * | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
| US5958905A (en) * | 1996-03-26 | 1999-09-28 | Texas Biotechnology Corporation | Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| CN1067821C (zh) * | 1997-03-13 | 2001-06-27 | 倚天资讯股份有限公司 | 一种互联网实时广播装置及其方法 |
| US5783705A (en) * | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| TR200101905T2 (tr) | 1997-04-28 | 2002-06-21 | Texas Biotechnology Corporation | Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler. |
| WO1999049866A1 (fr) | 1998-03-31 | 1999-10-07 | Tanabe Seiyaku Co., Ltd. | Agents prophylactiques/therapeutiques contre les troubles urinaires |
| CN1312807A (zh) | 1998-06-19 | 2001-09-12 | 希龙公司 | 糖元合成酶激酶3的抑制剂 |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6136971A (en) * | 1998-07-17 | 2000-10-24 | Roche Colorado Corporation | Preparation of sulfonamides |
| GB0013368D0 (en) * | 2000-05-31 | 2000-07-26 | Pfizer Ltd | Enzymatic oxidations |
| CA2315614C (en) | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
| AU2001263850A1 (en) * | 2000-04-20 | 2001-11-07 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfonamides having endothelin-antagonist activity |
| AU2001265871A1 (en) * | 2000-04-25 | 2001-11-07 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
| US6610518B2 (en) | 2000-05-31 | 2003-08-26 | Pfizer Inc. | Enzymatic oxidations |
| CA2348847A1 (en) * | 2000-05-31 | 2001-11-30 | Pfizer Inc. | New isoxazole-sulfonamide endothelin antagonists |
| US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
| MY140724A (en) | 2000-07-21 | 2010-01-15 | Actelion Pharmaceuticals Ltd | Novel arylethene-sulfonamides |
| US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| US20020091114A1 (en) | 2000-10-04 | 2002-07-11 | Odile Piot-Grosjean | Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity |
| AU2011218661B2 (en) * | 2002-05-24 | 2012-07-05 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| EP1507756B1 (en) | 2002-05-24 | 2015-07-22 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
| EP2256116A3 (en) * | 2002-11-18 | 2011-11-16 | ChemoCentryx, Inc. | Aryl sulfonamides |
| US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
| US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
| BR0316724A (pt) | 2002-12-02 | 2005-10-18 | Actelion Pharmaceuticals Ltd | Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas |
| US20050131028A1 (en) * | 2003-09-11 | 2005-06-16 | Pharmacia Corporation | Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders |
| JP4717876B2 (ja) | 2004-03-05 | 2011-07-06 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐ２ｘ３およびｐ２ｘ２／３アンタゴニストとしてのジアミノピリミジン |
| TW200628467A (en) | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
| CA2620129C (en) | 2005-09-01 | 2014-12-23 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| CN101253159B (zh) | 2005-09-01 | 2011-12-07 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 |
| CA2619919C (en) | 2005-09-01 | 2014-04-01 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| RU2435585C2 (ru) * | 2006-04-13 | 2011-12-10 | Актелион Фармасьютиклз Лтд | Антагонисты рецептора эндотелина, предназначенные для ранней стадии идиопатического фиброза легких |
| AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
| ATE530531T1 (de) * | 2007-12-18 | 2011-11-15 | Dipharma Francis Srl | Verfahren zur herstellung von bosentan |
| CA2724737A1 (en) * | 2008-05-19 | 2009-11-26 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
| US20110263623A1 (en) * | 2008-08-12 | 2011-10-27 | Cadila Healthcare Limited | Process for preparation of bosentan |
| WO2011078143A1 (ja) * | 2009-12-22 | 2011-06-30 | 塩野義製薬株式会社 | ピリミジン誘導体およびそれらを含有する医薬組成物 |
| WO2014093230A2 (en) * | 2012-12-10 | 2014-06-19 | Merck Patent Gmbh | Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
| SG11202002267UA (en) * | 2017-09-12 | 2020-04-29 | Agency Science Tech & Res | Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferase |
| CN107778254A (zh) * | 2017-12-07 | 2018-03-09 | 陈国妃 | 抗病毒药物中间体氧代二嘧啶衍生物的合成方法 |
| TWI833430B (zh) * | 2021-11-08 | 2024-02-21 | 大陸商正大天晴藥業集團股份有限公司 | 氮雜聯苯類化合物及其應用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545944A1 (de) * | 1964-06-19 | 1969-12-11 | Hoffmann La Roche | Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe |
| TW270116B (zh) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| TW287160B (zh) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche |
-
1994
- 1994-12-12 IL IL11195994A patent/IL111959A/xx not_active IP Right Cessation
- 1994-12-13 CA CA002137953A patent/CA2137953C/en not_active Expired - Fee Related
- 1994-12-14 AU AU80461/94A patent/AU676620B2/en not_active Ceased
- 1994-12-15 ES ES94119833T patent/ES2111237T3/es not_active Expired - Lifetime
- 1994-12-15 TW TW083111723A patent/TW430661B/zh not_active IP Right Cessation
- 1994-12-15 FI FI945900A patent/FI115137B/fi not_active IP Right Cessation
- 1994-12-15 DE DE69406900T patent/DE69406900T2/de not_active Expired - Lifetime
- 1994-12-15 EP EP94119833A patent/EP0658548B1/en not_active Expired - Lifetime
- 1994-12-15 DK DK94119833.5T patent/DK0658548T3/da active
- 1994-12-15 SG SG1996000959A patent/SG52234A1/en unknown
- 1994-12-15 AT AT94119833T patent/ATE160341T1/de not_active IP Right Cessation
- 1994-12-16 US US08/356,958 patent/US5589478A/en not_active Expired - Lifetime
- 1994-12-16 MY MYPI94003378A patent/MY130908A/en unknown
- 1994-12-17 CN CN94119413A patent/CN1051544C/zh not_active Expired - Fee Related
- 1994-12-17 KR KR1019940034840A patent/KR100250176B1/ko not_active IP Right Cessation
-
1996
- 1996-04-24 US US08/636,981 patent/US5728706A/en not_active Expired - Lifetime
-
1998
- 1998-01-08 GR GR980400025T patent/GR3025855T3/el unknown
- 1998-04-27 HK HK98103547A patent/HK1004333A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE160341T1 (de) | 1997-12-15 |
| DK0658548T3 (da) | 1998-03-16 |
| HK1004333A1 (en) | 1998-11-20 |
| MY130908A (en) | 2007-07-31 |
| IL111959A (en) | 2000-07-16 |
| ES2111237T3 (es) | 1998-03-01 |
| EP0658548A1 (en) | 1995-06-21 |
| FI945900A (fi) | 1995-06-18 |
| GR3025855T3 (en) | 1998-04-30 |
| DE69406900D1 (de) | 1998-01-02 |
| SG52234A1 (en) | 1998-09-28 |
| US5728706A (en) | 1998-03-17 |
| DE69406900T2 (de) | 1998-04-09 |
| AU676620B2 (en) | 1997-03-13 |
| AU8046194A (en) | 1995-06-22 |
| KR100250176B1 (ko) | 2000-09-01 |
| CA2137953C (en) | 2002-03-26 |
| CN1111242A (zh) | 1995-11-08 |
| FI945900A0 (fi) | 1994-12-15 |
| EP0658548B1 (en) | 1997-11-19 |
| FI115137B (fi) | 2005-03-15 |
| US5589478A (en) | 1996-12-31 |
| CN1051544C (zh) | 2000-04-19 |
| IL111959A0 (en) | 1995-06-29 |
| CA2137953A1 (en) | 1995-06-18 |
| KR950017972A (ko) | 1995-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW430661B (en) | Benzenesulfonamide derivative and process for preparing thereof | |
| AU666702B2 (en) | Morphinan derivative and medicinal use | |
| PT1159279E (pt) | 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais | |
| AU6052594A (en) | New heterocyclic compounds | |
| MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
| WO2002000650A3 (en) | Novel compounds possessing antibacterial, antifungal or antitumor activity | |
| ES468119A1 (es) | Un procedimiento para la preparacion de triazinas | |
| AU2267495A (en) | Benzamide derivatives as vasopressin antagonists | |
| IE780515L (en) | Morphine derivatives | |
| ES2013664A6 (es) | Un procedimiento para preparar derivados de nucleosidos de aciclopiramidina sustituidos en la posicion 6. | |
| ZA988668B (en) | Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them | |
| ATE81655T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung. | |
| IE780514L (en) | Morphine derivatives | |
| EP0407594A4 (en) | Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients | |
| CA2207100A1 (en) | Pyrimidine derivatives | |
| IE840158L (en) | Pharmaceutical composition. | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| GB2340490A (en) | Diphenylacetic acid derivatives and their use as antiviral agents | |
| TW360630B (en) | A secoaporphine compounds on arrhythmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent | ||
| MM4A | Annulment or lapse of patent due to non-payment of fees |